UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 144

Sortiert nach

Multicentric neoadjuvant pilot Phase II study of cetuximab combined with docetaxel in operable triple negative breast cancer

International journal of cancer, 2016-05, Vol.138 (9), p.2274-2280

2016

Volltextzugriff (PDF)

Neoadjuvant endocrine therapy with or without palbociclib in low-risk patients: a phase III randomized double-blind SAFIA trial

Journal of cancer research and clinical oncology, 2023-08, Vol.149 (9), p.6171-6179

2023

Volltextzugriff (PDF)

Anastrozole Is Superior to Tamoxifen as First-Line Therapy for Advanced Breast Cancer in Postmenopausal Women: Results of a North American Multicenter Randomized Trial

Journal of clinical oncology, 2000-11, Vol.18 (22), p.3758-3767

2000

Volltextzugriff (PDF)

Comprehensive side-effect profile of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: long-term safety analysis of the ATAC trial

The lancet oncology, 2006-08, Vol.7 (8), p.633-643

2006

Volltextzugriff (PDF)

A multicentre, international neoadjuvant, double-blind, randomized phase III trial comparing fulvestrant to a combination of fulvestrant and palbociclib (CDK 4/6 inhibitor) in patients with operable luminal breast cancer responding to fulvestrant (SAFIA study)

Annals of oncology, 2018-10, Vol.29, p.viii85-viii85

2018

Volltextzugriff (PDF)

Anastrozole (Arimidex™) versus tamoxifen as first-line therapy for advanced breast cancer in postmenopausal women: survival analysis and updated safety results

European journal of cancer (1990), 2003-08, Vol.39 (12), p.1684-1689

2003

Volltextzugriff (PDF)

Mastectomy with immediate breast reconstruction after neoadjuvant chemotherapy and radiation therapy. A new option for patients with operable invasive breast cancer. Results of a 20 years single institution study

European journal of surgical oncology, 2011-10, Vol.37 (10), p.864-870

2011

Volltextzugriff (PDF)

Phase III, Multicenter, Double-Blind, Randomized Study of Letrozole, an Aromatase Inhibitor, for Advanced Breast Cancer Versus Megestrol Acetate

Journal of clinical oncology, 2001-07, Vol.19 (14), p.3357-3366

2001

Volltextzugriff (PDF)

A longitudinal prospective study of health-related quality of life in breast cancer patients following high-dose chemotherapy with autologous blood stem cell transplantation

Bone marrow transplantation (Basingstoke), 2005-08, Vol.36 (3), p.251-259

2005

Volltextzugriff (PDF)

Prospective Randomized Trial of Docetaxel Versus Mitomycin Plus Vinblastine in Patients With Metastatic Breast Cancer Progressing Despite Previous Anthracycline-Containing Chemotherapy

Journal of clinical oncology, 1999-05, Vol.17 (5), p.1413-1424

1999

Volltextzugriff (PDF)

Efficacy of tamoxifen following anastrozole (‘Arimidex’) compared with anastrozole following tamoxifen as first-line treatment for advanced breast cancer in postmenopausal women

European journal of cancer (1990), 2003-11, Vol.39 (16), p.2310-2317

2003

Volltextzugriff (PDF)

Programme personnalisé de l’après cancer (PPAC): Quels sont les facteurs clés de succès de sa mise en œuvre ?

Oncologie (Paris, France), 2011-06, Vol.13 (6), p.295-302

2011

Volltextzugriff (PDF)

Multicenter, randomized comparative study of two doses of paclitaxel in patients with metastatic breast cancer

Journal of clinical oncology, 1996-06, Vol.14 (6), p.1858-1867

1996

Volltextzugriff (PDF)

Aromatase inhibitors in the management of early breast cancer

European journal of surgical oncology, 2008-11, Vol.34 (11), p.1199-1207

Nabholtz, J.M

2008

Volltextzugriff (PDF)

Growth Factors and Cytokines Upregulate Gelatinase Expression in Bone Marrow CD34+ Cells and Their Transmigration Through Reconstituted Basement Membrane

Blood, 1999-05, Vol.93 (10), p.3379-3390

1999

Volltextzugriff (PDF)

Late lines of treatment benefit survival in metastatic breast cancer in current practice?

Breast (Edinburgh), 2011-12, Vol.20 (6), p.574-578

2011

Volltextzugriff (PDF)

Advanced breast cancer updates on anastrozole versus tamoxifen

Journal of steroid biochemistry and molecular biology, 2003-09, Vol.86 (3), p.321-325

Nabholtz, J.M

2003

Volltextzugriff (PDF)

New adjuvant strategies for breast cancer: Meeting the challenge of integrating chemotherapy and trastuzumab (Herceptin)

Seminars in oncology, 2001-02, Vol.28 (1 Suppl 3), p.1-12

2001

Volltextzugriff (PDF)

Prognostic Value of Initial Tumor Parameters After Metastatic Relapse

Cancer investigation, 2011-11, Vol.29 (9), p.635-643

2011

Volltextzugriff (PDF)

Taxane/Anthracycline Combinations: Setting a New Standard in Breast Cancer?

The oncologist (Dayton, Ohio), 2001-01, Vol.6 (S3), p.5-12

2001

Volltextzugriff (PDF)

Myasthenia gravis in association with allogeneic bone marrow transplantation : clinical observations, therapeutic implications and review of literature

Bone marrow transplantation (Basingstoke), 1997-05, Vol.19 (9), p.939-942

1997

Volltextzugriff (PDF)

Ocular toxicity and cancer chemotherapy: A review

Cancer, 1996-10, Vol.78 (7), p.1359-1373

1996

Volltextzugriff (PDF)

Docetaxel (Taxotere) plus doxorubicin-based combinations: the evidence of activity in breast cancer

Seminars in oncology, 1999-06, Vol.26 (3 Suppl 9), p.7

Nabholtz, J M

1999

Volltextzugriff (PDF)

A phase II trial of triamcinolone hexacetanide for symptomatic recurrent malignant ascites

Journal of pain and symptom management, 2000-03, Vol.19 (3), p.193-199

2000

Volltextzugriff (PDF)

1 – 25 von 144

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(135)
Mit Volltextzugriff
(111)

Publikationsform

Artikel
(144)

Sprache

Erscheinungsjahr

n.n

Thema

Humans
(76)
Female
(62)
Life Sciences & Biomedicine
(58)
Science & Technology
(58)
Oncology
(50)
Breast Neoplasms - Drug Therapy
(45)
Biological And Medical Sciences
(37)
Middle Aged
(36)
Medical Sciences
(35)
Aged
(31)
Adult
(30)
Chemotherapy
(28)
Breast Neoplasms - Pathology
(27)
Breast Cancer
(24)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(23)
Pharmacology. Drug Treatments
(21)
Antineoplastic Agents
(19)
Neoplasm Metastasis
(19)
Treatment Outcome
(17)
Taxoids
(15)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Multicentric neoadjuvant phase II study of panitumumab combined with an anthracycline/taxane-based chemotherapy in operable triple-negative breast cancer: identification of biologically defined signatures predicting treatment impact

Multicentric neoadjuvant pilot Phase II study of cetuximab combined with docetaxel in operable triple negative breast cancer

Neoadjuvant endocrine therapy with or without palbociclib in low-risk patients: a phase III randomized double-blind SAFIA trial

Anastrozole Is Superior to Tamoxifen as First-Line Therapy for Advanced Breast Cancer in Postmenopausal Women: Results of a North American Multicenter Randomized Trial

Comprehensive side-effect profile of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: long-term safety analysis of the ATAC trial

A multicentre, international neoadjuvant, double-blind, randomized phase III trial comparing fulvestrant to a combination of fulvestrant and palbociclib (CDK 4/6 inhibitor) in patients with operable luminal breast cancer responding to fulvestrant (SAFIA study)

Anastrozole (Arimidex™) versus tamoxifen as first-line therapy for advanced breast cancer in postmenopausal women: survival analysis and updated safety results

Mastectomy with immediate breast reconstruction after neoadjuvant chemotherapy and radiation therapy. A new option for patients with operable invasive breast cancer. Results of a 20 years single institution study

Phase III, Multicenter, Double-Blind, Randomized Study of Letrozole, an Aromatase Inhibitor, for Advanced Breast Cancer Versus Megestrol Acetate

A longitudinal prospective study of health-related quality of life in breast cancer patients following high-dose chemotherapy with autologous blood stem cell transplantation

Prospective Randomized Trial of Docetaxel Versus Mitomycin Plus Vinblastine in Patients With Metastatic Breast Cancer Progressing Despite Previous Anthracycline-Containing Chemotherapy

Efficacy of tamoxifen following anastrozole (‘Arimidex’) compared with anastrozole following tamoxifen as first-line treatment for advanced breast cancer in postmenopausal women

Programme personnalisé de l’après cancer (PPAC): Quels sont les facteurs clés de succès de sa mise en œuvre ?

Multicenter, randomized comparative study of two doses of paclitaxel in patients with metastatic breast cancer

Aromatase inhibitors in the management of early breast cancer

Growth Factors and Cytokines Upregulate Gelatinase Expression in Bone Marrow CD34+ Cells and Their Transmigration Through Reconstituted Basement Membrane

Late lines of treatment benefit survival in metastatic breast cancer in current practice?

Advanced breast cancer updates on anastrozole versus tamoxifen

New adjuvant strategies for breast cancer: Meeting the challenge of integrating chemotherapy and trastuzumab (Herceptin)

Prognostic Value of Initial Tumor Parameters After Metastatic Relapse

Taxane/Anthracycline Combinations: Setting a New Standard in Breast Cancer?

Myasthenia gravis in association with allogeneic bone marrow transplantation : clinical observations, therapeutic implications and review of literature

Ocular toxicity and cancer chemotherapy: A review

Docetaxel (Taxotere) plus doxorubicin-based combinations: the evidence of activity in breast cancer

A phase II trial of triamcinolone hexacetanide for symptomatic recurrent malignant ascites

Suchergebnisse filtern